Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAzienda Ospedaliera Universitaria Integrata Verona

About this trial

This is a randomized controlled trial comparing patients with obstructive jaundice due to malignancies of the perihilar area of bile ducts and undergoing both preoperative and palliative biliary drainage. The comparison will focus on the technique:, on the one hand, an arm of patients undergoing standard-of-care ERCP with trans-papillary plastic protesis placement, and on the other hand, an experimental arm of patients undergoing suprapapillary plastic protesis placement with no sphincterotomy. The primary objective will be to compare the time-to-stent dysfunction in the two groups; secondary objectives will include a comparison of the safety, technical, and clinical success of the procedures.

Eligibility criteria

Qualifiers

Radiological/ biochemical/pathological diagnosis of malignant OJ.

Stenosis maximum extent may be 2 cm after biliary confluence.

Documented obstructive jaundice (serum bilirubin > 3 mg/dL).

Indication for biliary drainage (preoperative or palliative).

Disqualifiers

Contraindications to endoscopic approach (duodenal stenosis, surgically altered anatomy).

Previous sphincterotomy or drainage.

Involvement of the papilla of Vater by the tumour.

Uncontrolled coagulopathy (INR > 1.5 uncorrectable or <50.000 PLTs).

Trial design

Treatments tested in this trial

  • ERCP with suprapapillary stent placement
  • ERCP with transpapillary stent placement

Treatment groups

70 Participants
are divided into 2 treatment groups

Locations

This trial has no locations